Deborah Ruggeri

Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state

Silvia Buonamici, Emanuela Ottaviani, Nicoletta Testoni et al. · Blood · 2002 · 152 citations · Full text

Medicine, Hematology, Oncology +14

Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation

Simona Soverini, Michèle Cavo, Claudia Cellini et al. · Blood · 2003 · 120 citations · Full text

Medicine, Cancer Biology, Oncology +17

3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features.

Nicoletta Testoni, Gabriela Borsaru, Giovanni Martinelli et al. · PubMed · 1999 · 91 citations

Life Sciences, Genetics, Hematology +17

Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage

Francesca Re, Mario Arpinati, Nicoletta Testoni et al. · Experimental Hematology · 2002 · 48 citations · Full text

Life Sciences, Cell Biology, Immunology +13

Complex variant Philadelphia translocations involving the short arm of chromosome 6 in chronic myeloid leukemia.

Roberta La Starza, Nicoletta Testoni, Mårina Lafage‐Pochitaloff et al. · PubMed · 2002 · 25 citations

Life Sciences, Genetics, Hematology +17